Vicarious Surgical(RBOTW)
Focus: Vicarious Surgical develops robotic surgical systems focused on neurology applications. The company is newly public (Nasdaq listing application filed March 2026) and operates in the high-growth surgical robotics segment.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Vicarious Surgical?
AI assessmentHigh-risk, high-reward opportunity suitable only for risk-tolerant professionals willing to bet on technology platform survival and eventual clinical validation.
Why Work Here
- Entry into high-growth surgical robotics market with recent public listing momentum (Nasdaq application March 2026)
- Active R&D investment of $40M (FY2025) in emerging technology with neurology focus
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Vicarious Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.